We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
-15.64%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$5.07B
AUM Growth
-$1.15B
Cap. Flow
-$66.2M
Cap. Flow %
-1.31%
Top 10 Hldgs %
13.25%
Holding
305
New
19
Increased
108
Reduced
155
Closed
22

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$49.7M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$35.4M
3
LIN icon
Linde
LIN
+$28.7M
4
MSFT icon
Microsoft
MSFT
+$27.9M
5
KMI icon
Kinder Morgan
KMI
+$27.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$37.6M
2
PX
Praxair Inc
PX
+$30.5M
3
ENB icon
Enbridge
ENB
+$28.4M
4
LEG icon
Leggett & Platt
LEG
+$24.9M
5
T icon
AT&T
T
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 15.92%
2 Industrials 15.66%
3 Healthcare 14.91%
4 Financials 12.34%
5 Consumer Discretionary 11.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIMT
201
DELISTED
Aimmune Therapeutics
AIMT
$5.47M 0.11%
228,820
+42,627
+23% +$1.1M
PLAY icon
202
Dave & Buster's
PLAY
$349M
$5.43M 0.11%
121,920
-6,887
-5% -$387K
CCMP
203
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$5.26M 0.1%
55,211
-3,062
-5% -$300K
FOLD
204
DELISTED
Amicus Therapeutics
FOLD
$4.82M 0.1%
502,983
-5,150
-1% -$56.6K
APTI
205
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$4.5M 0.09%
118,543
-4,685
-4% -$158K
BHVN
206
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4.49M 0.09%
+121,306
New +$4.37M
ZGNX
207
DELISTED
Zogenix, Inc.
ZGNX
$4.26M 0.08%
116,989
-6,188
-5% -$253K
OLLI icon
208
Ollie's Bargain Outlet
OLLI
$4.76B
$3.96M 0.08%
+59,467
New +$4.95M
EPAY
209
DELISTED
Bottomline Technologies Inc
EPAY
$3.94M 0.08%
82,031
-34,860
-30% -$2.02M
HLI icon
210
Houlihan Lokey
HLI
$8.77B
$3.86M 0.08%
104,929
-3,717
-3% -$152K
TVTX icon
211
Travere Therapeutics
TVTX
$5.68B
$3.81M 0.08%
168,490
-9,576
-5% -$238K
THR
212
DELISTED
Thermon Group Holdings
THR
$3.79M 0.07%
186,618
-7,081
-4% -$160K
SPN
213
DELISTED
Superior Energy Services, Inc.
SPN
$3.53M 0.07%
105,483
-1,720
-2% -$119K
CUB
214
DELISTED
Cubic Corporation
CUB
$3.46M 0.07%
64,323
-4,330
-6% -$273K
BRKR icon
215
Bruker
BRKR
$8.69B
$3.23M 0.06%
108,593
-6,230
-5% -$197K
SHYF
216
DELISTED
The Shyft Group
SHYF
$3.06M 0.06%
422,619
-51,579
-11% -$480K
GWPH
217
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.98M 0.06%
+30,596
New +$4.01M
FET icon
218
Forum Energy Technologies
FET
$934M
$2.9M 0.06%
35,133
-3,909
-10% -$590K
ECPG icon
219
Encore Capital Group
ECPG
$1.98B
$2.87M 0.06%
122,078
-9,251
-7% -$249K
PTLA
220
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.69M 0.05%
137,540
-16,296
-11% -$335K
KNX icon
221
Knight Transportation
KNX
$11.2B
$2.54M 0.05%
101,411
-6,379
-6% -$198K
DY icon
222
Dycom Industries
DY
$12.1B
$2.24M 0.04%
41,443
-3,682
-8% -$247K
HRTG icon
223
Heritage Insurance Holdings
HRTG
$957M
$2.16M 0.04%
146,811
-8,714
-6% -$130K
IWO icon
224
iShares Russell 2000 Growth ETF
IWO
$14.9B
$1.97M 0.04%
+11,701
New +$2.18M
ICLR icon
225
Icon
ICLR
$12.8B
$1.86M 0.04%
14,431
+190
+1% +$26.2K
7 8
9
10 11

Similar funds

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $11.5B AUM 15.23% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return

GW&K Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, GW&K Investment Management held 305 positions worth $5.07B, down 18% from $6.22B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

GW&K Investment Management's Q4 2018 filing shows 19 new, 108 increased, 155 reduced and 22 closed positions. Its largest new stake was UnitedHealth: 188,034 shares worth $46.8M. The largest sale was GSK, an estimated $37.6M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Healthcare.

  • GW&K Investment Management's largest Q4 2018 buy was UnitedHealth: 188,034 shares worth $46.8M.
  • GW&K Investment Management added most to iShares Select Dividend ETF in Q4 2018, an estimated $24.2M increase.
  • GW&K Investment Management's biggest Q4 2018 reduction was AT&T, cutting an estimated $22.5M.
  • GW&K Investment Management fully exited GSK in Q4 2018, selling an estimated $37.6M.
  • GW&K Investment Management's ten largest holdings make up 13% of its $5.07B portfolio in Q4 2018.
  • GW&K Investment Management opened 19 new positions and closed 22 in Q4 2018.
  • GW&K Investment Management's portfolio value fell 18% quarter-over-quarter to $5.07B.

Based on GW&K Investment Management's 13F filing for Q4 2018, filed 7 Feb 2019.